Lymphoma Clinician Investigator

DANA-FARBER CANCER INSTITUTE

Dedicated to Discovery…Committed to Care Lymphoma Clinician Investigator The Department of Medical Oncology at Dana‑Farber Cancer Institute announces a search for a Clinician Investigator at the Instructor, Assistant Professor or Associate Professor level to join the DFCI Lymphoma Division. The successful candidate will participate in a very active, collegial, and expanding lymphoma program that supports both standard‑of‑care and research efforts in lymphoma, including chemotherapy, targeted therapy, immunotherapy and cellular therapy. Clinical responsibilities will include longitudinal outpatient care, inpatient lymphoma consultation, and inpatient hematologic malignancies service time. Candidates with an interest and demonstrated track record in translational research and interventional clinical trials are encouraged to apply. The successful candidate will engage in robust clinical service, clinical, and translational investigation, and the teaching of medical students, housestaff, and hematology/oncology fellows in the outpatient and inpatient settings. Academic rank at Harvard Medical School will be commensurate with experience, training and academic achievements. Applicants should have an M.D. or M.D./Ph.D., with ABIM certification and should have or be eligible for ABIM subspecialty certification in medical oncology or hematology. Applicants should e-mail a letter of interest, CV, and the names and email addresses of four references to: Matthew Davids, MD, MMSc Chief, Division of Lymphoma and Chair, Search Committee Dana‑Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 View email address on click.appcast.io and cc: Amy Kazmouski View email address on click.appcast.io Applications will be accepted until August 7, 2026 Dana‑Farber Cancer Institute is an NCI‑designated Comprehensive Cancer Center. We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy‑related conditions or any other characteristic protected by law. #J-18808-Ljbffr American Society of Clinical Oncology (ASCO)